Evidence map›Paper›PMID 38732120›Full record

ArticleInternational journal of molecular sciences2024

Adenosine A

Ana Carla L Nunes, Marta Carmo, Andrea Behrenswerth, Paula M Canas, Paula Agostinho, Rodrigo A Cunha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Adenosine AJournal of neurochemistry · 2026
    Article
  2. Article
  3. APurinergic signalling · 2026
    Article
  4. Article
  5. Article
  6. Special Issue "Adenosine Receptors in Health and Disease".International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Carla L NunesCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
Marta CarmoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
Andrea BehrenswerthCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
Paula M CanasCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
Paula AgostinhoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0001-5523-4945
Rodrigo A CunhaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0003-2550-6422

Funding

Centro2020 CENTRO-01-0145-FEDER-000008:BrainHealth2020Centro2020 CENTRO-01-0246-FEDER-000010Fundação para a Ciência e Tecnologia POCI-01-0145-FEDER-03127Fundação para a Ciência e Tecnologia UIDB/04539/2020La Caixa Foundation LCF/PR/HP17/52190001
6 · The paper itself

Abstract

Adenosine A

Indexed as

Adenosine A2 Receptor AntagonistsCorpus StriatumParkinson DiseaseReceptor, Adenosine A2AAnimalsDisease Models, AnimalDopaminergic NeuronsNeuroprotective AgentsPyrimidinesRatsRats, Sprague-DawleySubstantia NigraTriazoles5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidineAdenosine A2 Receptor AntagonistsNeuroprotective AgentsPyrimidinesReceptor, Adenosine A2ATriazolesA2A receptoradenosineParkinson’s diseasestriatumsubstantia nigrasynapse

Identifiers

PMID38732120
PMCPMC11084368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.